Skip to main content

Peer Review reports

From: Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients

Original Submission
7 Feb 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
16 Mar 2022 Reviewed Reviewer Report - Judith Exantus
28 Mar 2022 Reviewed Reviewer Report
28 Mar 2022 Reviewed Reviewer Report - Mara Medeiros
20 Apr 2022 Author responded Author comments - Xin Wei
Resubmission - Version 4
20 Apr 2022 Submitted Manuscript version 4
22 Apr 2022 Author responded Author comments - Xin Wei
Resubmission - Version 5
22 Apr 2022 Submitted Manuscript version 5
22 Apr 2022 Author responded Author comments - Xin Wei
Resubmission - Version 6
22 Apr 2022 Submitted Manuscript version 6
26 Apr 2022 Author responded Author comments - Xin Wei
Resubmission - Version 7
26 Apr 2022 Submitted Manuscript version 7
29 Jul 2022 Reviewed Reviewer Report - Mara Medeiros
9 Aug 2022 Reviewed Reviewer Report - Judith Exantus
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
10 Aug 2022 Editorially accepted
7 Sep 2022 Article published 10.1186/s12882-022-02914-4

You can find further information about peer review here.

Back to article page